Greenhouse Funds LLLP Buys Shares of 700,623 Mirion Technologies, Inc. (NYSE:MIR)

Greenhouse Funds LLLP bought a new position in Mirion Technologies, Inc. (NYSE:MIR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 700,623 shares of the company's stock, valued at approximately $12,226,000. Greenhouse Funds LLLP owned about 0.30% of Mirion Technologies at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of MIR. Tower Research Capital LLC TRC raised its holdings in shares of Mirion Technologies by 162.9% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,649 shares of the company's stock valued at $116,000 after acquiring an additional 4,120 shares in the last quarter. MetLife Investment Management LLC raised its holdings in Mirion Technologies by 5.9% in the 4th quarter. MetLife Investment Management LLC now owns 124,137 shares of the company's stock worth $2,166,000 after purchasing an additional 6,878 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Mirion Technologies by 2.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 7,185,694 shares of the company's stock worth $125,391,000 after purchasing an additional 171,918 shares during the period. Marshall Wace LLP boosted its stake in shares of Mirion Technologies by 287.5% during the 4th quarter. Marshall Wace LLP now owns 239,439 shares of the company's stock valued at $4,178,000 after purchasing an additional 177,643 shares in the last quarter. Finally, Bridgewater Associates LP bought a new stake in shares of Mirion Technologies during the 4th quarter valued at about $4,254,000. Hedge funds and other institutional investors own 78.51% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on MIR shares. Citigroup decreased their price target on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Robert W. Baird decreased their target price on Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday, April 4th. Finally, B. Riley dropped their price target on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating on the stock in a research report on Wednesday, April 16th. Four investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Buy" and an average target price of $18.75.

Mirion Technologies Stock Up 2.7 %

Shares of NYSE MIR traded up $0.40 on Friday, reaching $15.33. 1,394,744 shares of the company's stock traded hands, compared to its average volume of 1,679,348. The business's 50 day simple moving average is $14.53 and its two-hundred day simple moving average is $15.60. Mirion Technologies, Inc. has a 12 month low of $9.11 and a 12 month high of $18.81. The company has a market cap of $3.56 billion, a price-to-earnings ratio of -80.68 and a beta of 0.75. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43.

Mirion Technologies (NYSE:MIR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 11th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. Mirion Technologies had a positive return on equity of 4.78% and a negative net margin of 4.21%. As a group, equities research analysts forecast that Mirion Technologies, Inc. will post 0.39 EPS for the current fiscal year.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.